Elissaveta is the Head of Medical & Scientific Affairs at Vitaflo North America, where she provides strategic leadership across inherited metabolic disorders, pediatric kidney disease, and medical ketogenic diet therapy. Her work spans medical and scientific oversight across products, professional education, regulatory engagement, and the North America innovation pipeline. A long-standing GMDI member, Elissaveta has served as Editorial Committee Chair, 2024 GMDI Conference Co-Chair, 2026 GMDI Conference Chair, and currently serves as Communications & Advocacy Co-Chair, reflecting her commitment to leadership, collaboration, and supporting excellence in genetic metabolic nutrition practice.
Back to Board of Directors Page